These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 8356104)

  • 21. [Effect of serotoninergic substances on the brain potentials evoked by stimulation of the dental pulp].
    Degtiarev VP
    Farmakol Toksikol; 1978; 41(1):23-8. PubMed ID: 624386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Labeling in vivo of serotonin uptake sites in rat brain after administration of [3H]cyanoimipramine.
    Wolfe J; Kreider MS; Goodman C; Brunswick DJ
    J Pharmacol Exp Ther; 1987 Apr; 241(1):196-203. PubMed ID: 3572782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apomorphine-induced upregulation of serotonin 5-HT2A receptors in male rats is independent from development of aggressive behaviour.
    Matto V; Skrebuhhova T; Allikmets L
    J Physiol Pharmacol; 1999 Jun; 50(2):335-44. PubMed ID: 10424728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of chronic m-CPP on locomotion, hypophagia, plasma corticosterone and 5-HT2C receptor levels in the rat.
    Fone KC; Austin RH; Topham IA; Kennett GA; Punhani T
    Br J Pharmacol; 1998 Apr; 123(8):1707-15. PubMed ID: 9605579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The genetic characteristics of the brain alpha 2-adrenergic and S2-serotoninergic systems in the realization of the tail-jerk pain reflex and its morphine suppression in rats].
    Tiurina IV; Rusakov DIu; Sudakov SK
    Eksp Klin Farmakol; 1995; 58(2):22-4. PubMed ID: 7773081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [3H]tetrahydrotrazodone binding. Association with serotonin binding sites.
    Kendall DA; Taylor DP; Enna SJ
    Mol Pharmacol; 1983 May; 23(3):594-9. PubMed ID: 6865906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes in the properties of the 5-HT1 receptors in the brains of rats, the progeny of parents consuming morphine for a long time].
    Vekshina NL; Khristoliubova NA
    Eksp Klin Farmakol; 1992; 55(6):13-4. PubMed ID: 1305863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of psychiatric co-morbidity and efficacy of treatment in chronic daily headache in Indian population.
    Singh AK; Shukla R; Trivedi JK; Singh D
    J Neurosci Rural Pract; 2013 Apr; 4(2):132-9. PubMed ID: 23914085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of medication overuse headache in an interdisciplinary pain clinic.
    Schmid CW; Maurer K; Schmid DM; Alon E; Spahn DR; Gantenbein AR; Sandor PS
    J Headache Pain; 2013 Jan; 14(1):4. PubMed ID: 23565761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The analgesic effect of different antidepressants combined with aspirin on thermally induced pain in Albino mice.
    Elhwuegi AS; Hassan KM
    Libyan J Med; 2012; 7():. PubMed ID: 22529878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychiatric comorbidity and suicide risk in patients with chronic migraine.
    Pompili M; Serafini G; Di Cosimo D; Dominici G; Innamorati M; Lester D; Forte A; Girardi N; De Filippis S; Tatarelli R; Martelletti P
    Neuropsychiatr Dis Treat; 2010 Apr; 6():81-91. PubMed ID: 20396640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of activity of ketorolac in hot-plate test and serotonin binding capacity of brain membranes in rats.
    Vitale G; Sandrini M; Pini LA
    Agents Actions; 1994 May; 41(3-4):184-7. PubMed ID: 7942327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of brain serotonergic system in the antinociceptive action of acetylsalicylic acid in the rat.
    Pini LA; Sandrini M; Vitale G
    Inflamm Res; 1995 Jan; 44(1):30-5. PubMed ID: 7664027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of chronic treatment with phenazone on the hot-plate test and [3H]serotonin binding sites in pons and cortex membranes of the rat.
    Sandrini M; Vitale G; Pini LA; Sternieri E; Bertolini A
    Pharmacology; 1993 Aug; 47(2):84-90. PubMed ID: 8356104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of chronic treatment with phenazone on 3H-serotonin binding sites in pons and cortex membranes of the rat.
    Vitale G; Pini LA; Sandrini M
    Pharmacol Res; 1992; 25 Suppl 1():53-4. PubMed ID: 1508809
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of serotonin brain receptors in the analgesic effect of phenazone.
    Pini LA; Vitale G; Sandrini M
    Drugs Exp Clin Res; 1993; 19(1):13-8. PubMed ID: 8223135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naloxone-reversible antinociception by paracetamol in the rat.
    Pini LA; Vitale G; Ottani A; Sandrini M
    J Pharmacol Exp Ther; 1997 Feb; 280(2):934-40. PubMed ID: 9023309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain.
    Pini LA; Sandrini M; Vitale G
    Eur J Pharmacol; 1996 Jul; 308(1):31-40. PubMed ID: 8836629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.